144 related articles for article (PubMed ID: 37805057)
1. Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line.
Mamatis JE; Gallardo-Flores CE; Sangwan U; Tooley TH; Walsh T; Colpitts CC
Antiviral Res; 2023 Nov; 219():105730. PubMed ID: 37805057
[TBL] [Abstract][Full Text] [Related]
2. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
Ma-Lauer Y; Zheng Y; Malešević M; von Brunn B; Fischer G; von Brunn A
Antiviral Res; 2020 Jan; 173():104620. PubMed ID: 31634494
[TBL] [Abstract][Full Text] [Related]
3. Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
Berthold EJ; Ma-Lauer Y; Chakraborty A; von Brunn B; Hilgendorff A; Hatz R; Behr J; Hausch F; Staab-Weijnitz CA; von Brunn A
Front Cell Infect Microbiol; 2022; 12():958634. PubMed ID: 36211973
[TBL] [Abstract][Full Text] [Related]
4. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
5. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
6. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.
Carbajo-Lozoya J; Ma-Lauer Y; Malešević M; Theuerkorn M; Kahlert V; Prell E; von Brunn B; Muth D; Baumert TF; Drosten C; Fischer G; von Brunn A
Virus Res; 2014 May; 184():44-53. PubMed ID: 24566223
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
9. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
10. [Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].
Tian L; Liu W; Sun L
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):605-611. PubMed ID: 32347055
[TBL] [Abstract][Full Text] [Related]
11. Luteolin Isolated from
Hakem A; Desmarets L; Sahli R; Malek RB; Camuzet C; François N; Lefèvre G; Samaillie J; Moureu S; Sahpaz S; Belouzard S; Ksouri R; Séron K; Rivière C
Molecules; 2023 May; 28(11):. PubMed ID: 37298740
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
Bertram S; Dijkman R; Habjan M; Heurich A; Gierer S; Glowacka I; Welsch K; Winkler M; Schneider H; Hofmann-Winkler H; Thiel V; Pöhlmann S
J Virol; 2013 Jun; 87(11):6150-60. PubMed ID: 23536651
[TBL] [Abstract][Full Text] [Related]
13. Infection of human alveolar macrophages by human coronavirus strain 229E.
Funk CJ; Wang J; Ito Y; Travanty EA; Voelker DR; Holmes KV; Mason RJ
J Gen Virol; 2012 Mar; 93(Pt 3):494-503. PubMed ID: 22090214
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.
Duncan JKS; Xu D; Licursi M; Joyce MA; Saffran HA; Liu K; Gohda J; Tyrrell DL; Kawaguchi Y; Hirasawa K
Front Immunol; 2023; 14():930086. PubMed ID: 37197656
[TBL] [Abstract][Full Text] [Related]
15. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
Shirato K; Kanou K; Kawase M; Matsuyama S
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
[TBL] [Abstract][Full Text] [Related]
16. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
Hu Y; Jo H; DeGrado WF; Wang J
J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
Dehghan Z; Mirmotalebisohi SA; Mozafar M; Sameni M; Saberi F; Derakhshanfar A; Moaedi J; Zohrevand H; Zali H
Daru; 2024 Jun; 32(1):215-235. PubMed ID: 38652363
[TBL] [Abstract][Full Text] [Related]
18. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
[TBL] [Abstract][Full Text] [Related]
19. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
Molecules; 2020 May; 25(10):. PubMed ID: 32429580
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
Butot S; Baert L; Zuber S
Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
